We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cells Engineered for Tendon Repair

By Biotechdaily staff writers
Posted on 05 May 2006
A recent report described a method for transforming mesenchymal stem cells (MSCs) into tendon-like cells (tenocytes), which may lead to an advance in the treatment of injuries to tendons or ligaments.

Investigators at the Hebrew University of Jerusalem (Israel) implanted the gene for a biologically active variant of the Smad8 growth factor into an MSC line that co-expressed the osteogenic gene bone morphogenetic protein 2 (BMP2). More...
SMAD8 is a member of the MAD-related family of molecules. MAD-related proteins are a recently identified family of intracellular proteins that are thought to be essential components in the signaling pathways of the serine/threonine kinase receptors of the transforming growth factor beta super family. Bone morphogenetic proteins (BMPs) are growth factors belonging to the TGF-beta (transforming growth factor-beta) super family with a strong ability to induce new bone and/or cartilage formation.

The genetically engineered MSCs were implanted into rats with torn Achilles tendons. Results published in the April 2006 issue of the Journal of Clinical Investigation revealed that in their new environment the MRCs transformed into tenocytes capable of inducing tendon regeneration. This transformation was demonstrated by double quantum-filtered magnetic resonance imaging (MRI).

The authors concluded, "These findings may have considerable importance for the therapeutic replacement of tendons or ligaments and for engineering other tissues in which BMP plays a pivotal developmental role.”



Related Links:
Hebrew University of Jerusalem

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Automated Urinalysis Solution
UN-9000
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.